BioSpace News Archive

Hillrom previously announced its intention to acquire Bardy Diagnostics, Inc., an innovator in digital health and a leading provider of ambulatory cardiac monitoring.

Edwards Lifesciences announced new data from the COMMENCE clinical trial that demonstrate Edwards’ bioprosthetic surgical aortic valve with the company’s novel RESILIA tissue platform show favorable safety and hemodynamic performance through a median of five years follow-up.

MediciNova, Inc. announced the closing of the previously announced private placement transaction under a Securities Purchase Agreement, dated January 11, 2021, pursuant to which MediciNova issued US$20 million in shares of its common stock to 3D Opportunity Master Fund, a fund managed by 3D Investment Partners Pte. Ltd.

Illumina, Inc., the global leader in DNA sequencing and array-based technologies, and Sequoia Capital China, a leading investment firm, announced a collaboration to catalyze the startup ecosystem in China with the launch of the Sequoia Capital China Intelligent Healthcare Genomics Incubator, Powered by Illumina.

South Korea’s biotechnology firm Seegene said Monday it developed the world’s first COVID-19 diagnostic variant test, capable of screening COVID-19 and identifying multiple mutant variations in a single reaction.

Fourth patient, who spent more than two weeks in hospital and needed invasive mechanical ventilation, was treated with COVI-MSC starting Monday (January 25, 2021) and discharged last Friday (January 29, 2021) after 3rd COVI-MSC infusion

Yield10 Bioscience, Inc., an agricultural bioscience company, announced the pricing of its underwritten public offering of 1,040,000 shares of its common stock at a public offering price of $12.25 per share.